日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Mutational Signature in Cancers Following Solid Organ or Allogeneic Stem Cell Transplantation

实体器官或异基因干细胞移植后癌症的突变特征

Odintsov, Igor; Siegmund, Stephanie E; Mahadevan, Navin R; Church, Alanna J; Sholl, Lynette M; Nowak, Jonathan A

Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

对致癌MET融合基因的泛癌分析揭示了对MET靶向治疗具有不同敏感性的不同致病基因组亚群

Febres-Aldana Christopher A, Vojnic Morana, Odintsov Igor, Zhang Tom, Cheng Ryan, Beach Catherine Z, Lu Daniel, Mattar Marissa S, Gazzo Andrea M, Gili Leo, Harshan Manju, Ameri Ali, Machnicki Stephen, Xiao Xiuying, Lockwood William W, Zhou Xiao-Yan, Yao Qianlan, Drilon Alexander, Rekhtman Natasha, Shah Nameeta, Li Anqi, Liu Zebing, Yang Soo-Ryum, Davare Monika A, Ladanyi Marc, Somwar Romel

HER4 and EGFR Activate Cell Signaling in NRG1 Fusion-Driven Cancers: Implications for HER2-HER3-specific Versus Pan-HER Targeting Strategies

HER4 和 EGFR 激活 NRG1 融合驱动癌症中的细胞信号传导:对 HER2-HER3 特异性靶向与泛 HER 靶向策略的启示

Udagawa, Hibiki; Nilsson, Monique B; Robichaux, Jacqulyne P; He, Junqin; Poteete, Alissa; Jiang, Hong; Heeke, Simon; Elamin, Yasir Y; Shibata, Yuji; Matsumoto, Shingo; Yoh, Kiyotaka; Okazaki, Shogo; Masuko, Takashi; Odintsov, Igor; Somwar, Romel; Ladanyi, Marc; Goto, Koichi; Heymach, John V

Prevalence and Therapeutic Targeting of High-Level ERBB2 Amplification in NSCLC.

非小细胞肺癌中高水平ERBB2扩增的流行情况及治疗靶点

Odintsov Igor, Makarem Maisam, Nishino Mizuki, Bachert Sara Emily, Zhang Tom, LoPiccolo Jaclyn, Paweletz Cloud P, Gokhale Prafulla C, Ivanova Elena, Saldanha Aisha, Rudin Charles M, Lockwood William W, Ladanyi Marc, Somwar Romel, Jänne Pasi A, Sholl Lynette M

HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor

HER2抗体-药物偶联物对促纤维增生性小圆细胞肿瘤有效

Zhang, Tom; Febres-Aldana, Christopher A; Liu, Zebing; Dix, Jenna-Marie; Cheng, Ryan; Dematteo, Raymond G; Lui, Allan J W; Khodos, Inna; Gili, Leo; Mattar, Marissa S; Lisanti, Jeanine; Kwong, Charlene; Linkov, Irina; Tipping, Murray J; de Stanchina, Elisa; Odintsov, Igor; Ladanyi, Marc; Somwar, Romel

Preclinical evaluation of targeted therapies for central nervous system metastases

中枢神经系统转移瘤靶向治疗的临床前评估

Pfeil, Alexander J; Hale, Joshua D; Zhang, Tiger S; Wakayama, Kentaro; Miyazaki, Isao; Odintsov, Igor; Somwar, Romel

A visual-language foundation model for computational pathology

计算病理学的视觉语言基础模型

Lu, Ming Y; Chen, Bowen; Williamson, Drew F K; Chen, Richard J; Liang, Ivy; Ding, Tong; Jaume, Guillaume; Odintsov, Igor; Le, Long Phi; Gerber, Georg; Parwani, Anil V; Zhang, Andrew; Mahmood, Faisal

Zenocutuzumab, a HER2xHER3 Bispecific Antibody, Is Effective Therapy for Tumors Driven by NRG1 Gene Rearrangements.

Zenocutuzumab 是一种 HER2xHER3 双特异性抗体,可有效治疗由 NRG1 基因重排驱动的肿瘤

Schram Alison M, Odintsov Igor, Espinosa-Cotton Madelyn, Khodos Inna, Sisso Whitney J, Mattar Marissa S, Lui Allan J W, Vojnic Morana, Shameem Sara H, Chauhan Thrusha, Torrisi Jean, Ford Jim, O'Connor Marie N, Geuijen Cecile A W, Schackmann Ron C J, Lammerts van Bueren Jeroen J, Wasserman Ernesto, de Stanchina Elisa, O'Reilly Eileen M, Ladanyi Marc, Drilon Alexander, Somwar Romel

MYC Promotes Tyrosine Kinase Inhibitor Resistance in ROS1-Fusion-Positive Lung Cancer

MYC促进ROS1融合阳性肺癌对酪氨酸激酶抑制剂的耐药性

Iyer, Sudarshan R; Odintsov, Igor; Schoenfeld, Adam J; Siau, Evan; Mattar, Marissa S; de Stanchina, Elisa; Khodos, Inna; Drilon, Alexander; Riely, Gregory J; Ladanyi, Marc; Somwar, Romel; Davare, Monika A

Corrigendum: Functional impact and targetability of PI3KCA, GNAS, and PTEN mutations in a spindle cell rhabdomyosarcoma with MYOD1 L122R mutation

更正:PI3KCA、GNAS 和 PTEN 突变在伴有 MYOD1 L122R 突变的梭形细胞横纹肌肉瘤中的功能影响和靶向性

Choo, Florence; Odintsov, Igor; Nusser, Kevin; Nicholson, Katelyn; Davis, Lara; Corless, Christopher L; Stork, Linda; Somwar, Romel; Ladanyi, Marc; Davis, Jessica L; Davare, Monika A